Professor and Deputy Director, Australian Regenerative Medicine Institute
- Globally renowned expertise in regenerative medicine
- Utilise Australia’s largest university’s excellent facilities and reputation
Based in Melbourne, Monash University is Australia’s largest university and its Faculty of Medicine, Nursing and Health Sciences is home to a number of leading medical and biomedical research institutes and groups. Our expertise in life sciences and biomedicine is recognised both nationally and internationally. Established through a joint venture between Monash University and the Victorian Government, the Australian Regenerative Medicine Institute (ARMI) builds on the University's existing strengths in biomedical research and supports the critical infrastructure required to deliver the next generation of discoveries in regenerative medicine.
ARMI is one of the world's largest regenerative medicine and stem cell research centres, comprising 18 research groups, and a total of 270 researchers, students and support staff from 21 different countries . Its scientists are focused on unraveling the basic mechanisms of the regenerative process, enabling doctors to prevent, halt and reverse damage to vital organs due to disease, injury or genetic conditions. The vision promoted at ARMI is to exploit and connect the multidisciplinarity of its groups, aligning their complementary capacities around five key research pipelines; Heart and muscle development and regeneration, Immunity and regeneration, Stem cells and regeneration, Neural regeneration and Organ Engineering and Synthetic Biology. For more information visit www.armi.org.au/
Expression of Interest
Expressions of interest in all areas of regenerative, biomedical and stem cell research are welcome, but we are particularly interested in clinician scientists and those researchers focused on cardiac biology, Alzheimer and dementia and those with an interest in organoid biology. Those with a focus on clinical research and with research expertise that complements those of current investigators at the Institute are of particular interest. The University is an inaugural member of the SAGE pilot of the Athena SWAN accreditation program and has a strong focus on helping women advance STEMM disciplines and suitably qualified female scientists are encouraged to apply.
The Professor and Deputy Director will be expected to maintain a vigorous research program that addresses fundamental questions in the broad field of regenerative medicine. The incumbent will be expected to provide dynamic leadership and vision, assist in the management of the Institute and strengthen the Institute and the University’s profile and research and education networks, engaging with the broader research community, nationally and internationally.
To be considered you will need to possess a Ph.D. and/or MD, demonstrable leadership and vision, evidence of sustained competitive funding and an outstanding publication record of quality peer-reviewed science. An increasing focus on translational research is an integral part of the Institute’s research mission, and individuals that have a demonstrable ability to integrate clinical and basic science elements into a successful translational research program will be highly sought after.
The successful applicant will have access to state-of-the-art technological core facilities within the university, which include but are not restricted to advanced molecular preclinical and clinical imaging facilities, light-based micro-imaging, and state of the art animal facilities.
Professor Peter Currie, Director, phone + 61 3 990 29602, email email@example.com
All enquiries will be held in confidence.
Wednesday 31 January 2018, 11.55pm AEST and should include a cover letter, CV, publications list, a statement of previous research achievements, a research plan (max 8 pages) and details of 3 referees.